ROCKET PHARMACEUTICALS, INC. | Business Contracts

Underwriting Agreement, dated October 3, 2022, among Rocket Pharmaceuticals, Inc. and Morgan Stanley & Co. LLC, J.P. Morgan Securities LLC and SVB Securities LLC, as... (Filed With SEC on October 4, 2022)

Agreement and Plan of Merger, dated September 19, 2022, by and among Parent, the Company, Merger Sub I and Merger Sub II (Filed With SEC on September 20, 2022)

Sales Agreement, dated February 28, 2022, by and between the Company and Cowen and Company, LLC (Filed With SEC on March 1, 2022)

Offer Letter, dated April 29, 2021, by and between the registrant and Isabel Carmona (Filed With SEC on February 28, 2022)

Consulting Agreement between the Registrant and Gotham Makker, MD, dated June 16, 2020 (Filed With SEC on August 5, 2020)

Amended and Restated Lease Agreement, dated as of June 26, 2019, by and between Rocket Pharmaceuticals, Inc. and Cedar Brook 12 Corporate Center, L.P (Filed With SEC on August 8, 2019)

License Agreement, dated as of November 19, 2018, by and between Rocket Pharmaceuticals, Ltd. and REGENXBIO Inc (Filed With SEC on March 8, 2019)

Warrant to Purchase Shares of Common Stock, dated as of December 17, 2021, by and between the Registrant and Neptune Consulting, LLC. (Second Indication) (Filed With SEC on February 28, 2022)

Warrant to Purchase Shares of Common Stock, dated as of December 17, 2021, by and between the Registrant and Neptune Consulting, LLC. (First Indication) (Filed With SEC on February 28, 2022)

Offer Letter, dated September 29, 2017, by and between the Registrant and Raj Prabhakar (Filed With SEC on February 28, 2022)

Registration Rights Agreement, dated as of August 27, 2021, between Rocket Pharmaceuticals, Inc. and the purchaser party thereto (Filed With SEC on August 30, 2021)

Securities Purchase Agreement, dated as of August 27, 2021, between Rocket Pharmaceuticals, Inc. and the purchaser party thereto (Filed With SEC on August 30, 2021)

Description of Securities (Filed With SEC on March 1, 2021)

Warrant to Purchase Shares of Common Stock dated as of December 21, 2020, by and between the Registrant and Neptune Consulting, LLC (Filed With SEC on March 1, 2021)

Offer Letter, dated November 25, 2020, by and between the registrant and Carlos Garcia-Parada (Filed With SEC on March 1, 2021)

Underwriting Agreement, dated December 9, 2020, among Rocket Pharmaceuticals, Inc., J.P. Morgan Securities LLC, BofA Securities, Inc., SVB Leerink LLC and Piper Sandler & Co (Filed With SEC on December 11, 2020)

Second Supplemental Indenture, dated as of February 20, 2020, between Rocket Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (incorporated by... (Filed With SEC on June 12, 2020)

Offer Letter, dated September 25, 2019, by and between the registrant and Kamran Alam (Filed With SEC on March 6, 2020)

Form of Restricted Stock Unit Award Agreement (Filed With SEC on March 6, 2020)

Second Supplemental Indenture, dated as of February 20, 2020, between Rocket Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on February 20, 2020)

Amendment to First Supplemental Indenture, dated as of February 18, 2020, between Rocket Pharmaceuticals, Inc. and Wilmington Trust, National Association, as trustee (Filed With SEC on February 20, 2020)

Form of Exchange Agreement (Filed With SEC on February 11, 2020)

Underwriting Agreement, dated December 10, 2019, among Rocket Pharmaceuticals, Inc., J.P. Morgan Securities LLC, Cowen and Company, LLC and Evercore Group L.L.C (Filed With SEC on December 13, 2019)

Underwriting Agreement, dated April 15, 2019, among Rocket Pharmaceuticals, Inc., SVB Leerink LLC, Evercore Group L.L.C. and William Blair & Company, L.L.C (Filed With SEC on April 18, 2019)

Form of Severance and Change of Control Agreements, to be entered into between the Registrant and certain of its officers (Filed With SEC on March 8, 2019)

ROCKET PHARMACEUTICALS, INC. (25)